http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0108147-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05b3524a35c3949d76ee4051d8882477 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
filingDate | 1983-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13001fd578c93cf5bf3023943cddebbb |
publicationDate | 1984-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0108147-A1 |
titleOfInvention | Use of a protoberberine alkaloid and composition containing it. |
abstract | A composition containing a protoberberine alkaloid or its salt is effective in increasing the contractility of the heart in a mammal, as shown by a positive inotropic effect (evidenced by an increase in dP / dT and dF / dT) accompanied by at least one of the following symptoms: improved aortic blood circulation, decreased heart rate, decreased systemic blood pressure, reduced afterload of the left ventricle, decreased preload of the left ventricle, decreased calculated peripheral resistance of the vessels , decrease in average blood pressure and elimination of arrhythmia; its method of use is also described. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7858627-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7517867-B2 |
priorityDate | 1982-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 383.